+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Halozyme Inc - logo

Halozyme was founded in 1998, the headquarters are located in San Diego, California. It is a biotechnology company that innovates cancer therapies that target the tumor microenvironment. PEGPH20, their main proprietary programme applies a unique approach to targeting solid tumors it may help make existing treatments more effective by allowing therapies to reach the tumor. Halozyme has teamed up with many partnering companies such as: Roche, Pfizer, Janssen, Baxalta, AbbVie and Lilly for the NHANZE™ drug delivery technology platform.

From
From
Global Epinephrine Autoinjector Market 2023-2027 - Product Thumbnail Image

Global Epinephrine Autoinjector Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
From
From
From
Autoimmune Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 450 Pages +
  • Global
From
Global Autoinjectors Market 2023-2027 - Product Thumbnail Image

Global Autoinjectors Market 2023-2027

  • Report
  • March 2023
  • 165 Pages
  • Global
From
Contact Dermatitis - Pipeline Insight, 2020 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Pancreatic Ductal Carcinoma - Pipeline Insight, 2020 - Product Thumbnail Image

Pancreatic Ductal Carcinoma - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Type 2 Diabetes Mellitus- Pipeline Insight, 2022 - Product Thumbnail Image

Type 2 Diabetes Mellitus- Pipeline Insight, 2022

  • Drug Pipelines
  • March 2022
  • 100 Pages
  • Global
From
From
From
Loading Indicator